黒田祥平 (SHOHEI KURODA) - マイポータル - researchmap

基本情報

J-GLOBAL ID: 202101001857342879
researchmap会員ID: R000021538

論文

5

Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): An interventional, multicenter, open-label, single-arm clinical trial with clinical, ultrasound and biomarker assessments.

Toshimasa Shimizu, Shin-Ya Kawashiri, Tomohiro Koga, Rieko Kiya, Michiko Morita, Shohei Kuroda, Shigeki Tashiro, Shuntaro Sato, Hiroshi Yano, Tomoyuki Asano …

Drug discoveries & therapeutics 19(4) 253-261 2025年9月17日
Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab

Toshimasa Shimizu, Shin-ya Kawashiri, Tomohiro Koga, Rieko Kiya, Michiko Morita, Shohei Kuroda, Shigeki Tashiro, Shimpei Morimoto, Hiroshi Yano, Yukitaka Ueki …

Global Health & Medicine 7(4) 334-339 2025年8月31日
Examination of stabilization of sedation by Nasal High Flow in patients with endoscopic retrograde cholangiopancreatography during sedation using Dexmedetomidine.

Takao Ayuse, Shinji Kurata, Tomotaka Mori, Shohei Kuroda, Taiga Ichinomiya, Rintaro Yano, Gaku Mishima, Eisuke Ozawa, Stanislav Tatkov, Shuntaro Sato …

Medicine 102(23) e34004 2023年6月9日
Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial.

Toshimasa Shimizu, Shin-Ya Kawashiri, Shimpei Morimoto, Yurika Kawazoe, Shohei Kuroda, Rina Kawasaki, Yasuko Ito, Rieko Kiya, Shuntaro Sato, Hiroshi Yamamoto …

Trials 24(1) 161-161 2023年3月3日
Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): A study protocol for an interventional, multicenter, open-label and single-arm clinical trial with clinical, ultrasound and biomarker assessments.

Toshimasa Shimizu, Shin-Ya Kawashiri, Shuntaro Sato, Yurika Kawazoe, Shohei Kuroda, Rina Kawasaki, Yasuko Ito, Shimpei Morimoto, Hiroshi Yamamoto, Atsushi Kawakami

Medicine 101(2) e28463 2022年1月14日